Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest multiple sclerosis Stories

2013-08-25 23:00:33

Natural Sclerosis Multiple Treatment is a new E-book recently reviewed by http://www.SclerosisTreatment.com that promises to help patients cure MS permanently. Denver, Colorado (PRWEB) August 25, 2013 SclerosisTreatment.com a division of Ironclad Integrity Ltd has reviewed Dr. Gary M. Levin’s guide called Natural Multiple Sclerosis Treatment. The website states that this is a natural cure that showed very good results in numerous patients worldwide. http://www.SclerosisTreatment.com...

2013-08-19 23:01:22

http://www.SclerosisTreatment.com a division of Ironclad Integrity Ltd reviews one of the most efficient natural treatment that is leading the fight against Multiple Sclerosis. (PRWEB) August 19, 2013 According to Dr Gary Multiple Sclerosis Treatment review published by http://www.SclerosisTreatment.com, this natural method is effective in all cases. The new MS therapy was developed by Dr. Gary M. Levin, who spent years researching for an efficient treatment that could help patients...

2013-08-15 23:25:43

My Story - One Woman’s Journey With MS is a brand new multiple sclerosis treatment created by Val Moffat, who shares her own experience on struggling and overcoming MS naturally. A full My Story - One Woman’s Journey With MS overview on the site Healthreviewcenter.com shows if this new treatment is safe for sufferers to follow. Seattle, WA (PRWEB) August 15, 2013 My Story - One Woman’s Journey With MS is an informative multiple sclerosis treatment is developed by Val Moffat, who...

2013-08-15 11:57:15

No evidence that impaired blood flow or blockage in the veins of the neck or head is involved in MS There is no evidence that impaired blood flow or blockage in the veins of the neck or head is involved in multiple sclerosis, says a McMaster University study. The research, published online by PLOS ONE today, found no evidence of abnormalities in the internal jugular or vertebral veins or in the deep cerebral veins of any of 100 patients with multiple sclerosis (MS) compared with 100...

2013-08-14 23:00:49

http://www.SclerosisTreatment.com reviews one of the newest treatments available for multiple sclerosis. Dr. Gary M.Levin Multiple Sclerosis Treatment is a natural way to achieve permanent multiple sclerosis cure. Denver, Colorado (PRWEB) August 14, 2013 According to Dr Gary Multiple Sclerosis Treatment review published by http://www.SclerosisTreatment.com, this natural treatment is one of the most efficient ways of overcoming this disease. Dr Gary Multiple Sclerosis Treatment review...

2013-08-14 08:30:14

NEW YORK, Aug. 14, 2013 /PRNewswire/ -- The Tisch MS Research Center of New York announced today that it has received Investigational New Drug (IND) approval from the Food and Drug Administration (FDA) to commence a Phase 1 trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). MS is a chronic human autoimmune disease of the central nervous system that leads to myelin damage and neurodegeneration and affects approximately 2.1 million people worldwide....

2013-08-14 08:29:05

-- Progress Cited On Three Infectious Disease Programs, Including Two Programs in Collaboration with Intrexon Corporation; C. difficile Prophylactic is Lead Anti-Infective Candidate -- ROCKVILLE, Md., Aug. 14, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, today reported financial results for the three and six months ended June 30, 2013 and provided an operational update. The...

2013-08-14 04:20:36

-Sativex Already Undergoing Phase 3 Program in the U.S. as a Treatment for Cancer Pain- LONDON, Aug. 14, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW") announced today that it has opened a Phase 3 Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a pivotal efficacy and safety clinical program to evaluate Sativex® for the treatment of spasticity due to Multiple Sclerosis (MS). Sativex is currently approved in 22...

2013-08-09 12:22:44

DUBLIN, August 9, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5f7vxx/neuroprotection) have announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" [http://www.researchandmarkets.com/research/5f7vxx/neuroprotection ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the role of neuroprotection in acute disorders such as stroke and...

2013-08-08 23:18:50

New research from Kantar Health shows MS patients also have low quality of life regarding activities of daily living. New York, NY (PRWEB) August 08, 2013 Multiple sclerosis (MS) patients rate their quality of life lowest with respect to their relationships with family and friends and activities of daily living, according to new research from Kantar Health, a leading global healthcare advisory firm. MS patients’ overall quality of life is similar across all patient groups, with...